A lactating mother is given Iodine-131. What should be advised regarding breastfeeding?

NORCET 10 Prelims-2026

Pharmacology

Hard

Appeared in: NORCET 10 Prelims-2026

Explanation

Iodine-131 (I-131) is a radioactive isotope used in thyroid therapy that is actively concentrated and secreted into breast milk.
Ingestion of I-131 by an infant can destroy their thyroid gland (thyroid ablation) and significantly increases the lifetime risk of developing thyroid cancer.
I-131 has a long radioactive half-life of about 8 days, meaning it remains in the mother's system and milk for a prolonged period, making temporary cessation unsafe.
Due to the significant and prolonged risk to the infant, the standard and safest recommendation is to permanently stop breastfeeding for the current child.

Option A: Continuing to breastfeed would directly expose the infant to high levels of radiation, causing irreversible damage to the infant's thyroid gland.
Option B: A 24-hour waiting period is dangerously insufficient. The half-life of I-131 is 8 days, so a very high level of radioactivity would still be present in the breast milk after only one day.
Option C: Pumping and discarding milk for 7 days is not long enough. Since the half-life of I-131 is 8 days, more than 50% of the initial radioactivity would still be present in the milk after one week, posing a significant risk to the infant.

Visual 1: Table - A comparative table showing different radiopharmaceuticals (e.g., Iodine-131, Technetium-99m, Gallium-67), their half-lives, and the corresponding breastfeeding recommendations (e.g., permanent cessation, temporary cessation for X hours/days). This helps learners compare and contrast safety protocols.
Visual 2: Infographic - An infographic illustrating how Iodine-131 is ingested by the mother, concentrates in the breast milk, and then targets the infant's thyroid gland upon ingestion, highlighting the risk of thyroid ablation and cancer.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Breastfeeding guidelines after administration of radiopharmaceuticals (Iodine-131) as background academic context rather than a clinical decision trigger.
The nurse's primary role is patient education and safety. It is critical to provide clear, unambiguous instructions to the mother to prevent catastrophic harm to the infant. This includes explaining the 'why' behind the recommendation to ensure compliance.
Nurses must verify and communicate the specific recommendations for any radiopharmaceutical administered to a lactating mother, as guidelines vary significantly between isotopes. This often involves collaboration with the nuclear medicine department.
What if? If the mother had received Technetium-99m (Tc-99m) for a bone scan instead of I-131, the advice would be different. She would be advised to temporarily stop breastfeeding and discard her milk for 12 to 24 hours, after which it would be safe to resume.

How to Approach the Question

Identify the key clinical components of the question: a lactating mother and the administration of Iodine-131.
Recall the specific properties of Iodine-131: it is a radioactive isotope with a long half-life (approximately 8 days).
Remember the physiological behavior of iodine: it is actively concentrated by the thyroid gland and also in breast milk.
Evaluate the risk to the infant: Ingesting radioactive iodine would deliver a significant radiation dose to the infant's small thyroid gland, leading to tissue destruction and a high risk of future cancer.
Synthesize the information: Given the high concentration in milk and the long half-life, any temporary measure would be insufficient to protect the infant.
Conclude the safest course of action: The only way to eliminate the risk is to permanently cease breastfeeding for the current child. Evaluate the options and select the one that aligns with this conclusion.

Concept Tested & Keywords

Concept Tested: Breastfeeding guidelines after administration of radiopharmaceuticals (Iodine-131).
Stem keywords: lactating mother, Iodine-131, breastfeeding
Lead-in keywords: What should be advised
Clinical cues: Iodine-131 administration to a lactating mother is a critical safety scenario.

QAPXMhNoLRw95Io-E8oyB_